Belgian guidelines for non-occupational HIV post-exposure prophylaxis 2017

References

• Spira AI, Marx PA, Patterson BK, et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med. 1996;183:215–225.10.1084/jem.183.1.215
   PubMed Web of Science ®Google Scholar
• Tsai C-C, Emau P, Follis KE, et al. Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl)adenine treatment for prevention of persistent simian immunodeficiency virus sivmne infection depends critically on timing of initiation and duration of treatment. J Virol. 1998;72(5):4265–4273.
   PubMed Web of Science ®Google Scholar
• Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med. 1997;337(21):1485–1490.10.1056/NEJM199711203372101
   PubMed Web of Science ®Google Scholar
• Roland ME, Neilands TB, Krone MR, et al. Seroconversion following nonoccupational postexposure prophylaxis against HIV. Clin Infect Dis. 2005;41:1507–1513.10.1086/497268
   PubMed Web of Science ®Google Scholar
• Malinverni S, Libois A, Gennotte A-F, et al. Prescription of non-occupational post-exposure HIV prophylaxis by emergency physicians: an analysis on accuracy of prescription and compliance. PLOS ONE. 2016;11(4):e0153021. DOI:10.1371/journal.pone.0153021.
   PubMed Web of Science ®Google Scholar
• Kahn JO, Martin JN, Roland ME, et al. Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP study. J Infect Dis. 2001;183(5):707–714. DOI:10.1086/318829.
   PubMed Web of Science ®Google Scholar
• Cresswell F, Waters L, Briggs E, et al. UK guideline for the use of HIV post-exposure prophylaxis following sexual exposure, 2015. Int J STD AIDS. 2016;27(9):713–738.
   PubMed Web of Science ®Google Scholar
• Updated guidelines for antiretroviral postexposure prophylaxis after sexual, Injection-drug use, or other nonoccupational exposure to HIV-United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:458. DOI:10.15585/mmwr.mm6517a5).
   PubMedGoogle Scholar
• British Association for Sexual Health and HIV CEG framework for guideline development and assessment 2014. http://www.bashh.org/documents/GUIDELINESFRAMEWORKApril2015.pdf
   Google Scholar
• Vanden Berghe W, Nostlinger C, Buvé A, et al. A venue-based HIV prevalence and behavioural study among men who have sex with men in Antwerp and Ghent, Flanders, Belgium, October 2009 to March 2010. Euro Surveill. 2011;16(28):19914.
   Google Scholar
• UNAIDS HIV estimates 2015. Accessed June 28, 2017. http://www.unaids.org/en/regionscountries/countries.
   Google Scholar
• Loos J, Nöstlinger C, Vuylsteke B, et al. First HIV prevalence estimates of a representative sample of adult sub-Saharan African migrants in a European city. Results of a community-based, cross-sectional study in Antwerp, Belgium. PLOS ONE. 2017;12(4):e0174677. PMID: 28380051. DOI:10.1371/journal.pone.0174677.
   PubMed Web of Science ®Google Scholar
• Arco DA, Ibidun F, Thomadakis C, et al. High levels of post-migration HIV acquisition within nine European countries. AIDS. 2017;31(14):1979–1988. DOI:10.1097/QAD.0000000000001571.
   PubMed Web of Science ®Google Scholar
• http://www.unaids.org/en/resources/campaigns/2014/2014gapreport/gapreport
   Google Scholar
• del Romero J, Marincovich B, Castilla J, et al. Evaluating the risk of HIV transmission through unprotected orogenital sex. AIDS. 2002;16(9):1296–1297.10.1097/00002030-200206140-00017
   PubMed Web of Science ®Google Scholar
• Grant RM, Wiley JA, Winkelstein W. Infectivity of the human immunodeficiency virus: estimates from a prospective study of homosexual men. J Infect Dis. 1987;156(1):189–193.
   PubMed Web of Science ®Google Scholar
• Samuel MC, Hessol N, Shiboski S, et al. Factors associated with human immunodeficiency virus seroconversion in homosexual men in three San Francisco cohort studies, 1984–1989. J Acquir Immune Defic Syndr. 1993;6(3):303–312.
   PubMed Web of Science ®Google Scholar
• Vittinghoff E, Douglas J, Judson F, et al. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol. 1999;150(3):306–311.10.1093/oxfordjournals.aje.a010003
   PubMed Web of Science ®Google Scholar
• Mastro TD, Kitayaporn D. HIV type 1 transmission probabilities: estimates from epidemiological studies. AIDS Res Hum Retroviruses. 1998;14(Suppl 3):S223–7.
   PubMed Web of Science ®Google Scholar
• Royce RA, Sena A, Cates W Jr, et al. Sexual transmission of HIV. N Engl J Med. 1997;336(15):1072–1078.10.1056/NEJM199704103361507
   PubMed Web of Science ®Google Scholar
• Baggaley RF, White RG, Boily MC. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol. 2010;39(4):1048–1063.10.1093/ije/dyq057
   PubMed Web of Science ®Google Scholar
• DeGruttola V, Seage GR 3rd, Mayer KH, et al. Infectiousness of HIV between male homosexual partners. J Clin Epidemiol. 1989;42(9):849–856.10.1016/0895-4356(89)90098-X
   PubMed Web of Science ®Google Scholar
• Jin F, Jansson J, Law M, et al. Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS. 2010;24(6):907–913.10.1097/QAD.0b013e3283372d90
   PubMed Web of Science ®Google Scholar
• De Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med. 1994;331(6):341–346.10.1056/NEJM199408113310601
   PubMed Web of Science ®Google Scholar
• Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet. 2001;357(9263):1149–1153.10.1016/S0140-6736(00)04331-2
   PubMed Web of Science ®Google Scholar
• Leynaert B, Downs AM, de Vincenzi I. Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European study group on heterosexual transmission of HIV. Am J Epidemiol. 1998;148(1):88–96.10.1093/oxfordjournals.aje.a009564
   PubMed Web of Science ®Google Scholar
• Downs AM, De Vincenzi I. Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. European study group in heterosexual transmission of HIV. J Acquir Immune Defic Syndr Hum Retrovirol.1996;11(4):388–395.
   Google Scholar
• Donnelly C, Leisenring W, Kanki P, et al. Comparison of transmission rates of HIV-1 and HIV-2 in a cohort of prostitutes in Senegal. Bull Math Biol. 1993;55(4):731–743.10.1007/BF02460671
   PubMed Web of Science ®Google Scholar
• Hayes RJ, Schulz KF, Plummer FA. The cofactor effect of genital ulcers on the per-exposure risk of HIV transmission in sub-Saharan Africa. J Trop Med Hyg. 1995;98(1):1–8.
   PubMed Web of Science ®Google Scholar
• Peterman TA, Stoneburner RL, Allen JR, et al. Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections. JAMA. 1988;259(1):55–58.10.1001/jama.1988.03720010033036
   PubMed Web of Science ®Google Scholar
• del Romero J, Marincovich B, Castilla J, et al. Evaluating the risk of HIV transmission through unprotected orogenital sex. AIDS. 2002;16(9):1296–1297.10.1097/00002030-200206140-00017
   PubMed Web of Science ®Google Scholar
• Ippolito G, Puro V, De Carli G. The risk of occupational human immunodeficiency virus infection in health care workers. Italian Multicenter Study. The Italian Study Group on Occupational Risk of HIV Infection. Arch Intern Med. 1993;153(12):1451–1458.10.1001/archinte.1993.00410120035005
   PubMedGoogle Scholar
• Kaplan EH. Modeling HIV infectivity: must sex acts be counted? J Acquir Immune Defic Syndr. 1990;3(1):55–61.
   PubMed Web of Science ®Google Scholar
• Control CfD. Case-control study of HIV seroconversion in healthcare workers after percutaneous exposure to HIV-infected blood France, United Kingdom and United States, January 1988–August 1994. Morb Mortal Wkly Rep. 1995;44:929–933
   PubMedGoogle Scholar
• Bell DM. Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. Am J Med. 1997;102(5B):9–15.10.1016/S0002-9343(97)89441-7
   PubMedGoogle Scholar
• Richman KM, Rickman LS. The potential for transmission of human immunodeficiency virus through human bites. J Acquir Immune Defic Syndr. 1993;6(4):402–403.
   PubMed Web of Science ®Google Scholar
• Wahn V, Kramer HH, Voit T, et al. Horizontal transmission of HIV infection between two siblings. Lancet. 1986;2(8508):694.10.1016/S0140-6736(86)90209-6
   PubMed Web of Science ®Google Scholar
• Leal L, León A, Torres B, et al. A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection. J Antimicrob Chemother. 2016;71(7):1987–1993. DOI:10.1093/jac/dkw049.
   PubMed Web of Science ®Google Scholar